Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.

COVID-19

Journal

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
ISSN: 1441-2772
Titre abrégé: Crit Care Resusc
Pays: Netherlands
ID NLM: 100888170

Informations de publication

Date de publication:
15 04 2020
Historique:
entrez: 16 4 2020
pubmed: 17 4 2020
medline: 17 4 2020
Statut: aheadofprint

Résumé

We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 (COVID-19). We hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple organ failure and death. Future steps in the understanding of the disease and in the identification of treatments may benefit from this definition and hypothesised sequence of events.

Identifiants

pubmed: 32294809
pii: Landoni_2020/06_0120
pmc: PMC10692450

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-97

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300
pubmed: 32228035
Am J Hematol. 2020 Jul;95(7):E156-E158
pubmed: 32267008
Lancet Rheumatol. 2020 May;2(5):e255-e256
pubmed: 32368737
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Immunol Rev. 2017 Nov;280(1):41-56
pubmed: 29027222
N Engl J Med. 2017 Aug 10;377(6):562-572
pubmed: 28792873
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Crit Care Resusc. 2020 Apr 01;22(2):91-94
pubmed: 32227819
Nat Rev Drug Discov. 2019 Sep;18(9):707-729
pubmed: 31324874
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Thorac Oncol. 2020 May;15(5):e65-e66
pubmed: 32194247

Auteurs

Fabio Ciceri (F)

Department of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Luigi Beretta (L)

Vita-Salute San Raffaele University, Milan, Italy.

Anna Mara Scandroglio (AM)

Vita-Salute San Raffaele University, Milan, Italy.

Sergio Colombo (S)

Vita-Salute San Raffaele University, Milan, Italy.

Giovanni Landoni (G)

Vita-Salute San Raffaele University, Milan, Italy. landoni.giovanni@hsr.it.

Annalisa Ruggeri (A)

Department of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Jacopo Peccatori (J)

Department of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Armando D'Angelo (A)

Coagulation Service and Thrombosis Research Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesco De Cobelli (F)

Vita-Salute San Raffaele University, Milan, Italy.

Patrizia Rovere-Querini (P)

Vita-Salute San Raffaele University, Milan, Italy.

Moreno Tresoldi (M)

Unit of General Medicine and Advanced Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lorenzo Dagna (L)

Vita-Salute San Raffaele University, Milan, Italy.

Alberto Zangrillo (A)

Vita-Salute San Raffaele University, Milan, Italy.

Classifications MeSH